Côte d’Ivoire has stopped mass drug administration (MDA) for lymphatic filariasis in 99% of endemic districts in the country following the likely interruption of transmission of in 98 districts as of FY23 (October 2022 – September 2023). Prevalence of infection has been reduced significantly in the remaining district due to ongoing MDA.
Cote d'Ivoire has reached the stop MDA threshold in all formerly endemic districts. In May 2024, it plans to conduct the last of its trachoma surveillance surveys in 14 districts. If the TF prevalence is <5% among children ages 1-9 years, then all formerly endemic districts will have maintained the threshold for at least two years in the absence of MDA, a requirement for elimination validation by the WHO. Cote d'Ivoire also began working on its trachoma elimination dossier.
The Act | West program provided technical assistance and financial support to develop Côte d’Ivoire’s national strategic plan for OV elimination in FY23. In addition, Act West supported the first pre-Stop MDA survey in the country in the same fiscal year. The strategic plan and the results of the pre-stop surveys will be used by the national onchocerciasis elimination committee to determine future OV interventions and assessments.
Standard Disease-Specific Indicators as of FY21
FY21 is October 2020 through September 2021
No ever-endemic districts have stopped MDA as of FY21
(i.e. have passed stop MDA survey, TAS1 (First Transmission Assessment Survey))
No ever-endemic districts in post-surveillance phase as of FY21
(i.e. have passed last surveillance survey, TAS3 (third Transmission Assessment Survey))
No persons no longer at risk as of FY21 among those who were ever at risk
of ever-endemic districts have stopped MDA as of FY21
(i.e. have passed stop MDA survey, TIS (Trachoma Impact Survey))*
*Roughly 50% of districts not yet mapped for Trachoma
of ever-endemic districts in post-MDA surveillance phase as of FY21
(i.e. have passed surveillance survey, TSS (Trachoma Surveillance Survey))
of persons no longer at risk as of FY21 among those who were ever at risk
of ever endemic districts have been treated at least once as of FY21
(in cases where a country has more treated districts reported than, ever endemic, the adjusted percent is 100%)
of ever endemic districts have been treated at least once as of FY21
*SCH is not supported by USAID
of ever endemic districts have been treated at least once as of FY21
*STH is not supported by USAID